EUVIMEDEUVIMED entdecken
Crossref

Corticosteroid treatment attenuates anxiety and mPFC-amygdala circuit dysfunction in allergic asthma

Kolsoum Dehdar, Morteza Mooziri, Ali Samii Moghaddam, Morteza Salimi, Milad Nazari, Samaneh Dehghan, Hamidreza Jamaati, Alireza Salimi, Mohammad Reza Raoufy

Life Sciences · 2023

DOI: 10.1016/j.lfs.2023.121373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Sciences, 2023. Verfasst von Kolsoum Dehdar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of M…. Hauptthemen laut MEDLINE: Quality of Life, Asthma. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Tarbiat Modares University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Allergic asthma is associated with anxiety-related behaviors, leading to poor quality of life. Previous studies mainly described the neuropathophysiology of asthma-induced anxiety. However, the effects of corticosteroids, the most common anti-inflammatory agents for asthma treatment, on the neurophysiological foundations of allergic asthma-induced anxiety are unexplored. MAIN METHODS: Here, we evaluated lung and brain inflammation as well as anxiety in an animal model of allergic asthma pretreated with inhaled fluticasone propionate. Furthermore, to define the neurophysiological bases of these conditions, we studied the medial prefrontal cortex (mPFC)-amygdala circuit, which is previously shown to accompany asthma-induced anxiety. KEY FINDINGS: Our data showed that allergen induces anxiety, mPFC and amygdala inflammation, as well as disruptions in the local and long-range oscillatory activities within the mPFC-amygdala circuit. Interestingly, we observed a roughly consistent trend of changes with inhaled fluticasone pretreatment. Namely, the asthma-induced behavioral, inflammatory, and neurophysiological changes were partly, but not totally, prevented by inhaled fluticasone pretreatment. SIGNIFICANCE: We suggest that early treatment of asthmatic patients with inhaled corticosteroids improves mPFC-amygdala circuit function by attenuating neuroinflammation leading to reduced anxiety. These findings could lead clinical guidelines of asthma to consider the neuropsychiatric disorders of patients in treatment recommendations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeAsthmaAnimalsAndrostadienesFluticasonePrefrontal CortexAnxietyAmygdalaAdrenal Cortex HormonesAdministration, Inhalation

Stichwörter der Autor:innen

AmygdalaAnxietyAsthmaCorticosteroidmPFC

Substanzen

AndrostadienesFluticasoneAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
  • Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark; DANDRITE, The Danish Research Institute of Translational Neuroscience, Aarhus University, Aarhus, Denmark.
  • Stem Cell and Regenerative Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran; Eye Research Center, The Five Senses Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran…
  • Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran; Institute for Brain Sciences and Cognition, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Electro…

Förderung

  • Tarbiat Modares University

Zitieren

APA

Dehdar, K., Mooziri, M., Samii Moghaddam, A., Salimi, M., Nazari, M., Dehghan, S., Jamaati, H., Salimi, A., & Raoufy, M. R. (2023). Corticosteroid treatment attenuates anxiety and mPFC-amygdala circuit dysfunction in allergic asthma. Life Sciences. https://doi.org/10.1016/j.lfs.2023.121373

Vancouver

Dehdar K, Mooziri M, Samii Moghaddam A, Salimi M, Nazari M, Dehghan S, et al. Corticosteroid treatment attenuates anxiety and mPFC-amygdala circuit dysfunction in allergic asthma. Life Sciences. 2023. doi:10.1016/j.lfs.2023.121373

BibTeX
@article{Dehdar2023,
  author = {Dehdar, Kolsoum and Mooziri, Morteza and Samii Moghaddam, Ali and Salimi, Morteza and Nazari, Milad and Dehghan, Samaneh and Jamaati, Hamidreza and Salimi, Alireza and Raoufy, Mohammad Reza},
  title = {Corticosteroid treatment attenuates anxiety and mPFC-amygdala circuit dysfunction in allergic asthma},
  journal = {Life Sciences},
  year = {2023},
  doi = {10.1016/j.lfs.2023.121373}
}
Kostenlos starten →